JP2003286168A - α−リポイルアミノ酸を含有する皮膚外用剤 - Google Patents

α−リポイルアミノ酸を含有する皮膚外用剤

Info

Publication number
JP2003286168A
JP2003286168A JP2002090780A JP2002090780A JP2003286168A JP 2003286168 A JP2003286168 A JP 2003286168A JP 2002090780 A JP2002090780 A JP 2002090780A JP 2002090780 A JP2002090780 A JP 2002090780A JP 2003286168 A JP2003286168 A JP 2003286168A
Authority
JP
Japan
Prior art keywords
acid
lipoyl
skin
amino acid
external preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002090780A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003286168A5 (enrdf_load_stackoverflow
Inventor
Kazumi Ogata
一美 緒方
Kazuhiko Ito
和彦 伊藤
Yukihiro Sakagami
享宏 阪上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Priority to JP2002090780A priority Critical patent/JP2003286168A/ja
Publication of JP2003286168A publication Critical patent/JP2003286168A/ja
Publication of JP2003286168A5 publication Critical patent/JP2003286168A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Cosmetics (AREA)
JP2002090780A 2002-03-28 2002-03-28 α−リポイルアミノ酸を含有する皮膚外用剤 Pending JP2003286168A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002090780A JP2003286168A (ja) 2002-03-28 2002-03-28 α−リポイルアミノ酸を含有する皮膚外用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002090780A JP2003286168A (ja) 2002-03-28 2002-03-28 α−リポイルアミノ酸を含有する皮膚外用剤

Publications (2)

Publication Number Publication Date
JP2003286168A true JP2003286168A (ja) 2003-10-07
JP2003286168A5 JP2003286168A5 (enrdf_load_stackoverflow) 2005-08-04

Family

ID=29236033

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002090780A Pending JP2003286168A (ja) 2002-03-28 2002-03-28 α−リポイルアミノ酸を含有する皮膚外用剤

Country Status (1)

Country Link
JP (1) JP2003286168A (enrdf_load_stackoverflow)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007070303A (ja) * 2005-09-08 2007-03-22 Tateyama Kasei Kk α−リポ酸アルカリ塩の製法
JP2008156449A (ja) * 2006-12-22 2008-07-10 Sumitomo Rubber Ind Ltd 架橋剤およびこの架橋剤を含むゴム組成物およびこのゴム組成物を用いて製造したタイヤ
US7928067B2 (en) 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
JP4808781B2 (ja) * 2006-03-10 2011-11-02 ハン−ブル コスメティックス カンパニー リミテッド リポ酸誘導体及びこれを含有した皮膚外用剤組成物
JP2012188417A (ja) * 2011-02-21 2012-10-04 Daiichi Sankyo Healthcare Co Ltd AGEs生成抑制剤
US8815937B2 (en) 2010-11-18 2014-08-26 Ischemix Llc Lipoyl compounds and their use for treating ischemic injury
WO2017160269A1 (en) 2016-03-14 2017-09-21 Yu Ruey J N-lipoic -amino acid or peptide, derivatives and their uses
US10632089B2 (en) 2015-04-18 2020-04-28 Jo Cosmetics Co., Ltd. Tyrosinase activity inhibitor and external preparation for skin
US10744115B2 (en) 2017-04-25 2020-08-18 Ischemix Llc Compositions and methods for treating traumatic brain injury
US20220127242A1 (en) * 2016-03-14 2022-04-28 Neostrata Company, Inc. N-lipoic-amino acid or peptide, derivatives and their uses

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007070303A (ja) * 2005-09-08 2007-03-22 Tateyama Kasei Kk α−リポ酸アルカリ塩の製法
JP4808781B2 (ja) * 2006-03-10 2011-11-02 ハン−ブル コスメティックス カンパニー リミテッド リポ酸誘導体及びこれを含有した皮膚外用剤組成物
JP2008156449A (ja) * 2006-12-22 2008-07-10 Sumitomo Rubber Ind Ltd 架橋剤およびこの架橋剤を含むゴム組成物およびこのゴム組成物を用いて製造したタイヤ
US9540417B2 (en) 2009-05-14 2017-01-10 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
US7928067B2 (en) 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
US8772250B2 (en) 2009-05-14 2014-07-08 Ischemix, LLC Compositions and methods for treating ischemia and ischemia-reperfusion injury
US8772249B2 (en) 2009-05-14 2014-07-08 Ischemix, LLC Compositions and methods for treating ischemia and ischemia-reperfusion injury
US8815937B2 (en) 2010-11-18 2014-08-26 Ischemix Llc Lipoyl compounds and their use for treating ischemic injury
US9359325B2 (en) 2010-11-18 2016-06-07 Ischemix Llc Lipoyl compounds and methods for treating ischemic injury
JP2012188417A (ja) * 2011-02-21 2012-10-04 Daiichi Sankyo Healthcare Co Ltd AGEs生成抑制剤
US10632089B2 (en) 2015-04-18 2020-04-28 Jo Cosmetics Co., Ltd. Tyrosinase activity inhibitor and external preparation for skin
WO2017160269A1 (en) 2016-03-14 2017-09-21 Yu Ruey J N-lipoic -amino acid or peptide, derivatives and their uses
JP2019508506A (ja) * 2016-03-14 2019-03-28 ネオストラータ・カンパニー・インコーポレイテッドNeoStrata Company, Inc. N−リポアミノ酸又はペプチド、誘導体及びそれらの使用
EP3429577A4 (en) * 2016-03-14 2019-11-06 NeoStrata Company, Inc. N-lipoic amino acid or peptides, derivatives and their uses
US11155531B2 (en) 2016-03-14 2021-10-26 Neostrata Company, Inc. N-lipoic-amino acid or peptide, derivatives and their uses
US20220127242A1 (en) * 2016-03-14 2022-04-28 Neostrata Company, Inc. N-lipoic-amino acid or peptide, derivatives and their uses
EP4018997A1 (en) * 2016-03-14 2022-06-29 NeoStrata Company, Inc. N-lipoic -amino acid or peptide, derivatives and their uses
US10744115B2 (en) 2017-04-25 2020-08-18 Ischemix Llc Compositions and methods for treating traumatic brain injury
US11213509B2 (en) 2017-04-25 2022-01-04 Ischemix, LLC Compositions and methods for treating traumatic brain injury

Similar Documents

Publication Publication Date Title
JP4072062B2 (ja) 新規α−リポ酸誘導体およびその用途
US8048911B2 (en) Melanin eliminator preparation
JPS58113157A (ja) アンジオテンシン変換酵素阻害剤
JP2003286168A (ja) α−リポイルアミノ酸を含有する皮膚外用剤
EP3341380A1 (en) Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesia
EP0955046B1 (en) Amino acid derivatives as anti-inflammatory agents
US8927499B2 (en) Glycine derivative capable of inhibiting melanin formation and composition using the same
JP4341501B2 (ja) チロシナーゼ活性阻害剤
US8193156B1 (en) Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof
RU2017748C1 (ru) Производные нитратоалкановых кислот или их фармацевтически приемлемые соли
JP2011195516A (ja) 制がん剤
JP4259813B2 (ja) α−リポイルアミノ酸の安定化法および安定化されたα−リポイルアミノ酸を含有する水性液剤
EP4143161A1 (en) Process of making n,n-diacetyl-l-cystine disodium salt from cystine and acetyl chloride in methanol in the presence of sodium hydroxide
JPH0834779A (ja) トコフェロール誘導体
KR101154233B1 (ko) 타이로신 유도체를 함유하는 미백용 화장료 조성물
JP2006232685A (ja) メイラード反応阻害剤
US20230183176A1 (en) Process of making n,n'-diacetyl-l-cystine
JP6512546B2 (ja) ミモシン又はその誘導体を含有するシクロオキシナーゼ阻害剤、nadph−シトクロムp450レダクターゼ阻害剤及びチロシナーゼ阻害剤
TW201216996A (en) suitable for using as a skin-whitening active ingredient, and applied to a variety of whitening composition with good stability

Legal Events

Date Code Title Description
A521 Written amendment

Effective date: 20041227

Free format text: JAPANESE INTERMEDIATE CODE: A523

A621 Written request for application examination

Effective date: 20041227

Free format text: JAPANESE INTERMEDIATE CODE: A621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080826

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081024

A02 Decision of refusal

Effective date: 20081125

Free format text: JAPANESE INTERMEDIATE CODE: A02